| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,966 | 12,713 | 9,531 | 13,479 | | Cost of Revenue | 17,952 | 9,435 | 7,229 | 10,318 | | | Gross Profit | 5,014 | 3,278 | 2,302 | 3,161 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,756 | 4,217 | 4,554 | 5,668 | | Non Recurring |
-
|
-
|
-
| 27,192 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 258 | (939) | (2,252) | (29,699) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 |
-
|
-
| 60 | | Earnings Before Interest And Taxes | 259 | (939) | (2,252) | (29,639) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 259 | (939) | (2,252) | (29,639) | | Income Tax Expense | 101 | (358) | (881) | (2,243) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 158 | (581) | (1,371) | (27,396) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 158 | (581) | (1,371) | (27,396) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $158 | ($581) | ($1,371) | ($27,396) |
|
0.51% Nasdaq 
Income Statement
